<DOC>
	<DOCNO>NCT00766805</DOCNO>
	<brief_summary>Background : Both endoscopic variceal ligation ( EVL ) propranolol valuable method secondary prophylaxis variceal bleeding . Addition ISMN propranolol improve efficacy drug therapy . It hypothesize combination EVL portal pressure reduce drug significantly well EVL alone . Patients Methods : Patients history variceal bleed randomize EVL plus drug ( propranolol ISMN ) EVL alone . EVL repeat every 3-4 week variceal eradication . Propranolol dose adjust reduce rest heart rate 55 bpm . Dose ISMN 40 mg/d . Primary end point rebleed death . Secondary end point include complication portal hypertension development serious adverse effect therapy .</brief_summary>
	<brief_title>Endoscopic Variceal Ligation ( EVL ) + Drugs Versus Endoscopic Variceal Ligation ( EVL ) Alone For Secondary Prophylaxis</brief_title>
	<detailed_description />
	<mesh_term>Hypertension , Portal</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<mesh_term>Isosorbide-5-mononitrate</mesh_term>
	<mesh_term>Isosorbide Dinitrate</mesh_term>
	<mesh_term>Isosorbide</mesh_term>
	<criteria>Patients present G B Pant Hospital , New Delhi , history hematemesis and/or melena proven esophageal varix bleed source upper GI endoscopy include study . A history undergo endoscopic sclerotherapy ( EST ) , EVL , cyanoacrylate injection ; A history surgery portal hypertension ; Coexisting malignancy ; Severe cardiopulmonary renal disease ; A history severe sideeffects contraindication betablockers like bronchial asthma , uncontrolled diabetes mellitus , heart failure , peripheral vascular disease , prostatic hypertrophy , arterial hypotension ( systolic blood pressure &lt; 100 mm Hg ) , bradycardia ( basal heart rate &lt; 55 beat per minute ) , complete heart block ; Refusal give consent participate trial .</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2008</verification_date>
</DOC>